Yuria-Pharm - Strong at home, growing abroad
Nov 12, 2021
2 minutes
The sector capitalises on the country’s strong scientific knowledge base, relatively low costs, and access to both developed markets in Europe and emerging economies further afield. The domestic market is also strong, growing by 13% in 2020, according to industry figures, despite the deep recession caused by the covid-19 pandemic.
Yuria-Pharm, one of the country’s largest pharmaceutical companies, embodies the
You’re reading a preview, subscribe to read more.
Start your free 30 days